BNP Paribas Financial Markets Grows Stock Holdings in iShares Biotechnology ETF $IBB

BNP Paribas Financial Markets raised its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 313.2% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,915,395 shares of the financial services provider’s stock after buying an additional 1,451,820 shares during the period. BNP Paribas Financial Markets owned approximately 4.46% of iShares Biotechnology ETF worth $276,526,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Darwin Wealth Management LLC acquired a new stake in shares of iShares Biotechnology ETF in the 2nd quarter worth approximately $25,000. Financial Gravity Companies Inc. acquired a new position in iShares Biotechnology ETF during the second quarter worth $29,000. Ashton Thomas Securities LLC acquired a new position in iShares Biotechnology ETF during the third quarter worth $36,000. Parkside Financial Bank & Trust boosted its position in iShares Biotechnology ETF by 48.6% during the third quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock worth $38,000 after purchasing an additional 87 shares in the last quarter. Finally, Close Asset Management Ltd boosted its position in iShares Biotechnology ETF by 25.5% during the third quarter. Close Asset Management Ltd now owns 345 shares of the financial services provider’s stock worth $50,000 after purchasing an additional 70 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock opened at $172.27 on Wednesday. iShares Biotechnology ETF has a fifty-two week low of $107.43 and a fifty-two week high of $179.64. The stock’s fifty day moving average is $172.75 and its two-hundred day moving average is $162.09.

iShares Biotechnology ETF Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 19th. Investors of record on Tuesday, December 16th were paid a $0.1831 dividend. This represents a $0.73 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend was Tuesday, December 16th. This is a positive change from iShares Biotechnology ETF’s previous quarterly dividend of $0.08.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.